New Mountain Finance Reports Q2 Loss, NAV Decline Amid Asset Sale, Increases Share Buyback
NMFC is trading near its 52-week low of $6.73 (8.2% above the low).
Summary
New Mountain Finance Corp reported a Q2 net loss and NAV decline due to an asset sale and investment depreciation, but maintained its dividend and increased share repurchases.
Key Events · Earnings and Guidance · NMFC
-
Q2 Net Loss & NAV Decline
Reported a net loss of $88.5 million for the first half of 2026, driven by realized and unrealized losses. Net Asset Value (NAV) per share decreased to $10.89 as of June 30, 2026, from $11.52 at December 31, 2025.
-
Significant Asset Sale Completed
Completed a $468 million asset sale on March 10, 2026, at 94% of fair value (as of December 31, 2025). Proceeds were used to repay outstanding indebtedness and for general corporate purposes.
-
Increased Share Repurchase Program
Repurchased $65.6 million of common stock in the first half of 2026. The board authorized an additional $50 million, increasing the total repurchase program to $150 million, with $79.5 million remaining.
-
New Non-Accrual Investments
Several investments, including first lien positions in Convey Health Solutions, Inc. and Series A preferred shares in Symplr Software Intermediate Holdings, Inc., were placed on non-accrual status in Q1/Q2 2026.
Analysis · NMFC · Unknown
New Mountain Finance Corp reported a significant net loss and a decline in Net Asset Value per share for Q2 2026, primarily driven by realized losses from a $468 million asset sale and unrealized depreciation on several investments. Despite these financial headwinds, the company maintained its quarterly dividend, which was covered by adjusted net investment income. Management also aggressively repurchased shares and increased its buyback authorization, while successfully securing new private debt, indicating active capital management in a challenging environment.
At the time of this filing, NMFC was trading at $7.28 on NASDAQ in the Unknown sector, with a market capitalization of approximately $682.9M. The 52-week trading range was $6.73 to $10.71. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.